Bonus Issues

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE1060.0015.7 (+1.5 %)
PREV CLOSE ( ) 1044.30
OPEN PRICE ( ) 1044.00
BID PRICE (QTY) 1059.15 (6)
OFFER PRICE (QTY) 1060.75 (21)
VOLUME 5083
TODAY'S LOW / HIGH ( )1040.30 1060.85
52 WK LOW / HIGH ( )481.05 1068
NSE1060.0016 (+1.53 %)
PREV CLOSE( ) 1044.00
OPEN PRICE ( ) 1044.00
BID PRICE (QTY) 1059.30 (19)
OFFER PRICE (QTY) 1060.25 (1)
VOLUME 158353
TODAY'S LOW / HIGH( ) 1040.10 1061.15
52 WK LOW / HIGH ( )487.5 1070

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.